{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:58:07Z","timestamp":1792515487978,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10815-025-03496-4","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T07:29:49Z","timestamp":1746516589000},"page":"1773-1779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral GnRH antagonists for ovulation suppression during ovarian stimulation protocols: systemic review and meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-5026","authenticated-orcid":false,"given":"Nadav","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Zilbelicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Nahshon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha","family":"Seh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Oron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","volume":"84","author":"M Arslan","year":"2005","unstructured":"Arslan M, Bocca S, Mirkin S, et al. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005;84:555\u201369.","journal-title":"Fertil Steril"},{"key":"3496_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/oxfordjournals.humrep.a137323","volume":"6","author":"JP Toner","year":"1991","unstructured":"Toner JP, Brzyski RG, Oehninger S, et al. Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome. Hum Reprod. 1991;6:284\u20139.","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"3496_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1472-6483(11)60210-1","volume":"5","author":"O Ortmann","year":"2002","unstructured":"Ortmann O, Weiss JM, Diedrich K. Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action. Reprod Biomed Online. 2002;5(Suppl 1):1\u20137.","journal-title":"Reprod Biomed Online"},{"key":"3496_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","volume":"17","author":"H Al-Inany","year":"2002","unstructured":"Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod. 2002;17:874\u201385.","journal-title":"Hum Reprod"},{"key":"3496_CR5","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1021\/jm8006454","volume":"51","author":"C Chen","year":"2008","unstructured":"Chen C, Wu D, Guo Z, et al. Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem. 2008;51:7478\u201385.","journal-title":"J Med Chem"},{"key":"3496_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/1933719113497292","volume":"21","author":"MP Diamond","year":"2014","unstructured":"Diamond MP, Carr B, Dmowski WP, et al. Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study. Reprod Sci. 2014;21:363\u201371.","journal-title":"Reprod Sci"},{"key":"3496_CR7","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1210\/jc.2016-3845","volume":"102","author":"J Ng","year":"2017","unstructured":"Ng J, Chwalisz K, Carter DC, et al. Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women. J Clin Endocrinol Metab. 2017;102:1683\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"3496_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa1700089","volume":"377","author":"HS Taylor","year":"2017","unstructured":"Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377:28\u201340.","journal-title":"N Engl J Med"},{"key":"3496_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(22)01475-1","volume":"400","author":"J Donnez","year":"2022","unstructured":"Donnez J, Taylor HS, Stewart EA, et al. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet. 2022;400:896\u2013907.","journal-title":"Lancet"},{"key":"3496_CR10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"3496_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12422","volume":"21","author":"K Nakao","year":"2022","unstructured":"Nakao K, Kuroda K, Horikawa T, et al. Therapeutic effects of an oral gonadotropin-releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF. Reprod Med Biol. 2022;21: e12422.","journal-title":"Reprod Med Biol"},{"key":"3496_CR12","doi-asserted-by":"publisher","unstructured":"Mouanness M, Merhi Z. Elagolix represents a less invasive and cheaper option than injectable GnRH antagonist for ovulation suppression in IVF. J Clin Endocrinol Metab. Epub ahead of print March 14, 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae168.","DOI":"10.1210\/clinem\/dgae168"},{"key":"3496_CR13","first-page":"179","volume":"4","author":"C Boniface","year":"2023","unstructured":"Boniface C, Schnorr JN, Gray J, et al. The role of elagolix in the suppression of ovulation in donor oocyte cycles. F S Rep. 2023;4:179\u201382.","journal-title":"F S Rep"},{"key":"3496_CR14","doi-asserted-by":"publisher","unstructured":"Soliman D, Naoom R, Zaied M, et al. The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study. F&S Reports. Epub ahead of print . 2024. https:\/\/doi.org\/10.1016\/j.xfre.2024.06.006","DOI":"10.1016\/j.xfre.2024.06.006"},{"key":"3496_CR15","doi-asserted-by":"crossref","unstructured":"Al-Inany HG, Youssef MA, Ayeleke RO, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2016; 4: CD001750.","DOI":"10.1002\/14651858.CD001750.pub4"},{"key":"3496_CR16","doi-asserted-by":"publisher","unstructured":"Archer DF, Ng J, Chwalisz K, et al. Elagolix suppresses ovulation in a dose-dependent manner: results from a 3-month, randomized study in ovulatory women. J Clin Endocrinol Metab; 105. Epub ahead of print March 1, 2020. https:\/\/doi.org\/10.1210\/clinem\/dgz086.","DOI":"10.1210\/clinem\/dgz086"},{"key":"3496_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40262-019-00840-7","volume":"59","author":"M Shebley","year":"2020","unstructured":"Shebley M, Polepally AR, Nader A, et al. Clinical pharmacology of elagolix: an oral gonadotropin-releasing hormone receptor antagonist for endometriosis. Clin Pharmacokinet. 2020;59:297\u2013309.","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03496-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:47:38Z","timestamp":1751532458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03496-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03496-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as a systemic review and meta-analysis, no specific patient\u2019s data was recorded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}